Vikram Arora
Impact in
- General Dentistry top 10%
-
- Protease and Inhibitor Mechanisms
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Retinoids in leukemia and cellular processes 2
- Oncology 5
- Cancer-related Molecular Pathways 2
- Co-authors
- Patrick L. Iversen (13 shared papers)Gayathri R. Devi (4 shared papers)David Mason (1 shared paper)David A. Stein (2 shared papers)Dwight D. Weller (2 shared papers)Doreen L. Weller (1 shared paper)Christopher L. Corless (1 shared paper)Tomasz M. Beer (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)Journal of Allergy and Clinical Immunology (2 papers)Pharmaceutical Research (2 papers)Current Pharmaceutical Biotechnology (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Vikram Arora
34 papers receiving 708 citations
Peers
Comparison fields: 5 of 100
- General Dentistry 14
- Cancer Research 94
- Molecular Biology 431
- Oncology 114
- Pharmacology 33
Countries citing papers authored by Vikram Arora
This map shows the geographic impact of Vikram Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Arora more than expected).
Fields of papers citing papers by Vikram Arora
This network shows the impact of papers produced by Vikram Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Arora. The network helps show where Vikram Arora may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikram Arora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. | 2003 | 120 |
| 2 | 2005 | 93 | |
| 3 | 2003 | 83 | |
| 4 | 2002 | 65 | |
| 5 | 2000 | 63 | |
| 6 | 2004 | 58 | |
| 7 | 2016 | 28 | |
| 8 | 2002 | 27 | |
| 9 | 2000 | 25 | |
| 10 | 1998 | 20 | |
| 11 | 2015 | 20 | |
| 12 | 2002 | 19 | |
| 13 | 2011 | 18 | |
| 14 | 2017 | 16 | |
| 15 | 1998 | 15 | |
| 16 | 2012 | 9 | |
| 17 | 2005 | 8 | |
| 18 | 2017 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2020 | 6 |
About Vikram Arora
Vikram Arora is a scholar working on Molecular Biology, Oncology, Pharmacology, Hematology and Hepatology, having authored 37 papers that have together received 747 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Liver physiology and pathology (3 papers), Protease and Inhibitor Mechanisms (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Dental Research and COVID-19 (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in General Dentistry (14 citations), Cancer Research (94 citations), Molecular Biology (431 citations), Oncology (114 citations) and Pharmacology (33 citations). Vikram Arora has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Patrick L. Iversen, Gayathri R. Devi, David Mason, David A. Stein, Dwight D. Weller, Doreen L. Weller, Christopher L. Corless, Tomasz M. Beer, Harmanjatinder S. Sekhon and Sahil Thakar. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Allergy and Clinical Immunology, Pharmaceutical Research, Current Pharmaceutical Biotechnology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.